Early testing of a new drug combination that attacks the most common form of leukaemia on multiple fronts has shown great promise in targeting cancer cells.
Original Post on Medical News Today - Read More
Your comment (required):
Name (required):
Email (required):
Website
Back to Top
Leave a comment